Funder
Tokyo Metropolitan Hospital
Children's Cancer Association of Japan
Jikei University School of Medicine
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. W. Landier, S.H. Armenian, A.T. Meadows, et al. Late effects of childhood cancer and its treatment. P.A. Pizzo, D.G. Poplack (Eds.), Principles and Practice of Pediatric Oncology (seventh ed.), Wolters Kluwer, Philadelphia (2016). 1173–1196
2. Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61:223–242
3. Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Lopez-Novoa JM et al (2011) An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol 41:803–821
4. Cvitkovic E, Spaulding J, Bethune V et al (1977) Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 39:1357–1361
5. Hayes DM, Cvitkovic E, Golbey RB et al (1977) High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer 39:1372–1381